All answers will be known come Mid 2016.
IMHO we will be very successful. All the data from PC stages are there.
A partnership deal will be made. We will have AMD, Hep B and Lung Cancer ALL in FDA approval status or human trials.
Pfizer may take us out (at $40) but if not, we will have a SP of $25-$35.
Thats 2016. 2 years from now. Surely you can hold on and wait.
- Forums
- ASX - By Stock
- BLT
- Ann: Bioshares Clinical Trials Presentation
Ann: Bioshares Clinical Trials Presentation, page-8
-
-
- There are more pages in this discussion • 13 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)